Acute Pharyngitis or Acute attack of Chronic Pharyngitis
Conditions
Interventions
experiment group:Binglian Qingyan
control group 1:Jinsangzi
control group 2:Jinhoujian
Sponsors
Wuhan Union Hospital, Tongji Medical college, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Conform to the western medicine of acute pharyngitis or acute attack of chronic pharyngitis disease diagnostic criteria; (2) Acute onset, course of primary-care within 72 hours; (3) Male or female subjects aged 18-65; (4) No drug intervention or other treatment associated with acute pharyngitis or acute attack of chronic pharyngitis; (5) Voluntarily signed the informed consent and having good adherence.
Exclusion criteria
Exclusion criteria: (1) Patients with measles, scarlet fever, flu, agranulocytosis, infectious mononucleosis, such as leukemia, acute carotid inflammation caused by pharyngeal symptoms or inflammation; (2) Temperature higher than 38.5 degree; Blood WBC more than 10*10^9/L, or with pneumonia and bronchitis; Suppurative tonsillitis; (3) Pregnant or lactating women; (4) Patients with serious heart, brain, lung, liver, kidney disease, blood disease, or seriously affect the survival of the disease, such as cancer or AIDS; (5) ALT above 2 times more than normal reference range; (6) Allergic to the trial medicine; (7) Patients with disability according to the law (blind, deaf, mental retardation, mental disorder, physical disabilities, etc.); (8) Patients with history of having alcohol or drug abuse, or according to the judgment of the researchers, have lower possibility into the group or complicate the group's other lesions, such as working environment changeing frequently to cause lost to follow-up; (9) Patients were enrolled in other trial within last month; (10) Patients are taking part in other trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sore throat;pharyngeal mucosa irritation;uvula irritation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Other individual symptoms;physical signs of efficacy; | — |
Countries
China
Contacts
Public ContactWeijia Kong
Outcome results
None listed